D-1226-2014 Class III Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-1226-2014 was initiated by Hospira Inc. on Mar 25, 2014 and is designated Class III. Reason for recall: Labeling; Missing label; ampoules are missing the immediate container label The recall status is terminated (terminated Dec 18, 2015). Affected quantity: 237,850 ampoules.

Recall Details

Product Type
Drugs
Report Date
Apr 16, 2014
Initiation Date
Mar 25, 2014
Termination Date
Dec 18, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
237,850 ampoules

Product Description

Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.

Reason for Recall

Labeling; Missing label; ampoules are missing the immediate container label

Distribution Pattern

Nationwide

Code Information

Lot: 221303A, 1OCT2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1226-2014
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.